Latest Glp1 News and Updates : Glp1 updates, Glp1 News , Glp1 around the world

Nishadil

Washington | 20°C (overcast clouds)

A Tiny Pill Could Turn the Tide Against Heart Disease

Top story

A Tiny Pill Could Turn the Tide Against Heart Disease

In focus

Latest feed

The GLP-1 Effect: How Weight-Loss Drugs Are Sparking an Unexpected Boom in Aesthetics

RFK Jr. Pushes FDA to Open the Door on a Dozen Hot‑Talk Peptides

Samsung Biologics Strikes $1.8 Billion Deal for Swiss Peptide Maker PolyPeptide Group

America’s GLP‑1 Experiment on the Aging Population

Latest headlines

When GLP‑1 Drugs Trim You Down, Your Body Finds a Way to Fill the Space

When GLP‑1 Drugs Trim You Down, Your Body Finds a Way to Fill the Space

When Getting a GLP-1 is Too Easy: Yale Researchers' Undercover Study Raises Eyebrows

When Getting a GLP-1 is Too Easy: Yale Researchers' Undercover Study Raises Eyebrows

Is Food Constantly on Your Mind? Understanding the Silent Battle of 'Food Noise'

Is Food Constantly on Your Mind? Understanding the Silent Battle of 'Food Noise'

Navigating Summer with GLP-1 Medications: Your Essential Guide

Navigating Summer with GLP-1 Medications: Your Essential Guide

A Game Changer for Health? California Kicks Off Medicare Pilot to Cover Weight Loss Meds

A Game Changer for Health? California Kicks Off Medicare Pilot to Cover Weight Loss Meds

Medicare's Landmark Pilot: Weight-Loss Drugs Now Covered for Heart Health

Medicare's Landmark Pilot: Weight-Loss Drugs Now Covered for Heart Health

Medicare Takes a Landmark Step: Pilot Program to Cover Weight-Loss Drugs for Heart Patients

Medicare Takes a Landmark Step: Pilot Program to Cover Weight-Loss Drugs for Heart Patients

Medicare's Landmark Shift: Finally Covering Ozempic-Style Drugs for Cardiovascular Health

Medicare's Landmark Shift: Finally Covering Ozempic-Style Drugs for Cardiovascular Health

The Next Frontier: How Pharma is Redefining GLP-1 Success Beyond the Pill

The Next Frontier: How Pharma is Redefining GLP-1 Success Beyond the Pill

Pharma’s New Playbook: Merging Nutrition with GLP‑1 Therapy

Pharma’s New Playbook: Merging Nutrition with GLP‑1 Therapy

Do GLP‑1 Medications Raise Testosterone? What the Science Actually Shows

Do GLP‑1 Medications Raise Testosterone? What the Science Actually Shows

The Unexpected Side Effect of Weight Loss: Understanding 'Ghost Fat'

The Unexpected Side Effect of Weight Loss: Understanding 'Ghost Fat'

Novo Nordisk Shares Rise After UK Greenlights First Daily GLP‑1 Weight‑Loss Pill, Healing Breach‑Related Wounds

Novo Nordisk Shares Rise After UK Greenlights First Daily GLP‑1 Weight‑Loss Pill, Healing Breach‑Related Wounds

The Weight of Progress: Employers Grapple with GLP-1 Costs and Coverage

The Weight of Progress: Employers Grapple with GLP-1 Costs and Coverage

The Weight of Wellness: How GLP-1 Costs Are Reshaping Employer Healthcare

The Weight of Wellness: How GLP-1 Costs Are Reshaping Employer Healthcare

Boehringer Ingelheim’s Survodutide Shows Strong Weight‑Loss Results in Late‑Stage Trial

Boehringer Ingelheim’s Survodutide Shows Strong Weight‑Loss Results in Late‑Stage Trial

Semaglutide Generics: Can API Capacity Turn the Tide?

Semaglutide Generics: Can API Capacity Turn the Tide?

The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs

The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs

Mayim Bialik's GLP-1 Ordeal: A Candid Look at Severe Side Effects After One Shot

Mayim Bialik's GLP-1 Ordeal: A Candid Look at Severe Side Effects After One Shot

A New Chapter for Weight Loss: WW Leans into GLP-1s as Eli Lilly Explores Wider Medical Miracles

A New Chapter for Weight Loss: WW Leans into GLP-1s as Eli Lilly Explores Wider Medical Miracles

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 Weight‑Loss Drug Plan: What the Numbers Really Mean

Medicare’s $50 Weight‑Loss Drug Plan: What the Numbers Really Mean

Can Wegovy Really Shift New Zealand’s Obesity Landscape?

Can Wegovy Really Shift New Zealand’s Obesity Landscape?

The Protein Industrial Complex Is Here—And Fiber Is Knocking on the Door

The Protein Industrial Complex Is Here—And Fiber Is Knocking on the Door

Beyond the Scale: Unpacking the 'Ozempic Personality' and Its Emotional Ripples

Beyond the Scale: Unpacking the 'Ozempic Personality' and Its Emotional Ripples

The Weight Loss Revolution: Eli Lilly Unveils a New Horizon

The Weight Loss Revolution: Eli Lilly Unveils a New Horizon

Navigating the Hype: Are Popular Weight Loss Medications Right for *You*?

Navigating the Hype: Are Popular Weight Loss Medications Right for *You*?

The RFK Jr. Effect: How a Presidential Candidate's Peptides Push Sent Hims & Hers Stock Soaring

The RFK Jr. Effect: How a Presidential Candidate's Peptides Push Sent Hims & Hers Stock Soaring

The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun

The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

The Alarming Rise: GLP-1 Drugs Misused for Cosmetic Weight Loss in India

The Alarming Rise: GLP-1 Drugs Misused for Cosmetic Weight Loss in India

Imagine a Future: One Tiny Implant, Multiple Treatments for HIV, Obesity, and More

Imagine a Future: One Tiny Implant, Multiple Treatments for HIV, Obesity, and More

The Heart of the Matter: Do GLP-1 Medications Offer Lasting Protection, Or Is It A Momentary Truce?

The Heart of the Matter: Do GLP-1 Medications Offer Lasting Protection, Or Is It A Momentary Truce?

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

GLP-1 Medications: A Lifelong Partnership for Heart Health?

GLP-1 Medications: A Lifelong Partnership for Heart Health?

A Closer Look at GLP-1s: New Research Flags Potential Link to Sudden Sight Loss and 'Eye Stroke'

A Closer Look at GLP-1s: New Research Flags Potential Link to Sudden Sight Loss and 'Eye Stroke'

A New Chapter in Obesity Care: Novo Nordisk and Hims & Hers Team Up for Broader Access

A New Chapter in Obesity Care: Novo Nordisk and Hims & Hers Team Up for Broader Access

Navigating the Untamed Frontier: Why the GLP-1 Market Still Feels Like the Wild West

Navigating the Untamed Frontier: Why the GLP-1 Market Still Feels Like the Wild West

Load more